Related Experiment Video

Updated: Mar 26, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

1.0K

Re: Trends in Management for Patients with Localized Prostate Cancer, 1990-2013

David F Penson

    The Journal of Urology
    |February 9, 2016
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
    07:25

    A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

    Published on: March 6, 2018

    14.0K
    Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
    13:19

    Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

    Published on: November 2, 2013

    17.3K

    Related Experiment Videos

    Last Updated: Mar 26, 2026

    A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
    05:19

    A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

    Published on: November 7, 2025

    1.0K
    A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
    07:25

    A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

    Published on: March 6, 2018

    14.0K
    Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
    13:19

    Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

    Published on: November 2, 2013

    17.3K

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    9.1K
    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    9.1K
    Disorders of the Male Reproductive System01:20

    Disorders of the Male Reproductive System

    5.4K
    Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
    Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
    5.4K

    Articles linked to this work by shared authors, journal, and citation graph.

    Real-world outcomes of sipuleucel-T treatment in PROCEED, a prospective registry of men with metastatic castration-resistant prostate cancer.

    Cancer·2019

    Influence of the facility caseload on the subsequent survival of men with localized prostate cancer undergoing radical prostatectomy.

    Cancer·2019

    Interpretation of Domain Scores on the EPIC-How Does the Domain Score Translate into Functional Outcomes?

    The Journal of urology·2019

    Health Care Resource Utilization and Costs Associated with Corticosteroid Use in Patients with Castration-Resistant Prostate Cancer: An Administrative Claims Analysis.

    Journal of managed care & specialty pharmacy·2019

    The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus Statement.

    European urology·2019

    Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

    Journal of the National Comprehensive Cancer Network : JNCCN·2019

    2026 Updates to the Diagnosis and Treatment of Non-muscle Invasive Bladder Cancer: AUA/SUO Guideline.

    The Journal of urology·2026

    Factors and Reasons Influencing Compliance with Post-vasectomy Semen Analysis: A Systematic Review.

    The Journal of urology·2026

    Anastomotic Urethroplasty is Associated with a Lower Risk of Stricture Recurrence Compared to Buccal Mucosa Graft Onlay after Reconstruction for Radiation-Induced Bulbomembranous Urethral Stenosis.

    The Journal of urology·2026

    Non-Muscle Invasive Recurrence and Management During Surveillance in Patients with Muscle-Invasive Bladder Cancer Who Achieve Clinical Complete Response to Neoadjuvant Chemotherapy.

    The Journal of urology·2026

    Pre-operative circulating tumour DNA in high-risk primary cutaneous melanoma: prospective feasibility in molecular pathology.

    Acta oncologica (Stockholm, Sweden)·2026

    Prognostic Associations of BMI and Metabolic Syndrome With Outcomes After Anti-PD-1 Therapy in Recurrent or Metastatic Nasopharyngeal Carcinoma.

    Immunology·2026

    Integrating genetic predictors into subsequent breast cancer risk prediction in survivors of childhood cancer.

    Journal of the National Cancer Institute·2026

    Real-world treatment landscape and clinical outcomes in first-line advanced or metastatic gastroesophageal adenocarcinoma in the United States.

    The oncologist·2026

    Integrative multi-omics profiling of insomnia-related molecular features reveals microbiome, immune, and therapy-relevant heterogeneity in colorectal cancer.

    Microbiology spectrum·2026

    Predicting pancreatic cancer in high-risk individuals and in the general population: how long is the road yet?

    Revista espanola de enfermedades digestivas·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us